Sulfilatec

Sulfilatec, Inc. is a preclinical-stage biotechnology company aiming to transform clinical outcomes in dialysis. The company is developing novel treatments tailored to the unique biochemical profile of dialysis patients in order to reduce the elevated morbidity and mortality rates associated with dialysis treatments.